AAIC 2025 Abstract
Biomarker‐integrated Prognostic Stagings for Alzheimer's Disease
Study in peopleBiomarkers
Abstract
Background: Accurate staging of Alzheimer’s disease (AD) progression is crucial for optimizing patient care and therapeutic interventions; however, traditional cognition‐based classifications remain limited to capture the heterogeneity in individual risk.
